Author:
Fleeman Nigel,Bagust Adrian,Boland Angela,Beale Sophie,Richardson Marty,Krishan Ashma,Stainthorpe Angela,Abdulla Ahmed,Kotas Eleanor,Banks Lindsay,Payne Miranda
Funder
Health Technology Assessment Programme (GB)
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference38 articles.
1. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. Available from:
http://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf
. Accessed 1 June 2015.
2. National Institute for Health and Care Excellence (NICE). Melanoma (metastatic) - talimogene laherparepvec [ID508]. NICE in development [GID-TAG509]. Anticipated publication date: 01 July 2016. Available from:
https://www.nice.org.uk/guidance/indevelopment/gid-tag509
. Accessed 19 April 2016.
3. Cashin RP, Lui P, Machado M, Hemels ME, Corey-Lisle PK, Einarson TR. Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. Value Health. 2008;11(2):259–71.
4. Cassileth BR, Lusk EJ, Tenaglia AN. Patients’ perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg. 1983;71(1):73–5.
5. Elder DE, Dt G, Heiberger RM, LaRossa D, Goldman LI, Clark WH Jr, et al. Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg. 1983;71(1):66–72.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献